熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
aTyr Pharma 美國aTyr Pharma, Inc.
aTyr Pharma, Inc. 是致力于研發(fā)全新類別生物制劑的生物制藥公司。
aTyr Pharma 新型生物治療藥物的研發(fā)工具包括 tRNA 合成酶系列中的新型蛋白質(zhì)片段，這些蛋白質(zhì)片段擁有通常與 tRNA 合成酶相關(guān)的蛋白質(zhì)合成功能截然不同的細(xì)胞信號(hào)傳遞功能。這些蛋白片段，或稱為”resectins”，正被開發(fā)成治療血液異常、神經(jīng)退化性疾病、炎癥、心血管疾病和新陳代謝功能失調(diào)的新穎療法
aTyr Pharma discovers and develops protein therapeutics for human diseases. We are building a comprehensive intellectual property portfolio across a family of proteins and their biologically active components.
These biologics have therapeutic potential across a wide range of disease areas including vascular, inflammation, oncology, metabolic, neurologic and dermatologic disorders. Two novel biologics are currently in pre-clinical development.
aTyr Pharma also has established domestic and international collaborative corporate and academic partners for pre-clinical research and development. aTyr Pharma will select products from the development pipeline for internal development, corporate partnerships, and out-licensing.
知識(shí)產(chǎn)權(quán)侵權(quán)投訴：不生產(chǎn)任何產(chǎn)品所有產(chǎn)品均來自產(chǎn)品的生產(chǎn)廠商、代理商、經(jīng)銷商，如有侵權(quán)請(qǐng)聯(lián)系：400-006-7520 ，我們會(huì)在第一時(shí)間處理
本網(wǎng)站所有產(chǎn)品與藥品無關(guān)
滬公網(wǎng)安備31011502016460號(hào)
